• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮腔内血管支架置入术治疗恶性上腔静脉综合征:回顾性研究。

Percutaneous Endovascular Stent Placement for Treatment of Malignant Superior Vena Cava Syndrome: A Retrospective Review.

机构信息

Department of Cardiology, Jiading Branch of Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.

出版信息

Ann Vasc Surg. 2022 Mar;80:325-332. doi: 10.1016/j.avsg.2021.10.025. Epub 2021 Nov 12.

DOI:10.1016/j.avsg.2021.10.025
PMID:34780937
Abstract

BACKGROUND

We assessed the safety as well as the efficacy of self-expanding stent placement for the treatment of malignant superior vena cava syndrome (SVCS), besides identifying the predictable probable factors for the clinical improvement of endovascular stent treatment in SVCS.

METHODS

The study reviewed 112 patients (92 men) with malignant SVCS retrospectively from January 2015 to December 2020.

RESULTS

Out of total 112 patients, 106 stents were successfully placed in 102 patients, however 4 patient's occlusions could not be passed and 6 patient's procedure was abandoned due to intraluminal thrombus as detected in venography. In 92 patients, complete resolution of syndrome was observed within 72 hrs but 10 patients did not to intervention. In 102 patients, procedure-related 8 complications were noted including stent migrations (n = 4), pulmonary embolism (n = 2), and pulmonary edemas (n = 2). Besides after stenting, 3 hemorrhages with anticoagulation therapy were observed with 4 recurrences at 22, 36, 51 and day 58 in 6 months. The pressure gradient across the lesion (≥ 20mmHg) was used as a predictor for clinical efficacy of stent therapy for SVCS.

CONCLUSIONS

Endovascular stent insertion is a safe and effective intervention for malignant SVCS, especially for those with pressure gradient across the lesions ≥ 20mmHg.

摘要

背景

我们评估了自膨式支架置入治疗恶性上腔静脉综合征(SVCS)的安全性和疗效,并确定了预测 SVCS 血管内支架治疗临床改善的可能因素。

方法

本研究回顾性分析了 2015 年 1 月至 2020 年 12 月期间 112 例(92 例男性)恶性 SVCS 患者的资料。

结果

在 112 例患者中,102 例患者成功放置了 106 枚支架,但 4 例患者的支架无法通过堵塞部位,6 例患者因静脉造影显示管腔内血栓而放弃手术。92 例患者在 72 小时内综合征完全缓解,但 10 例患者未接受干预。在 102 例患者中,发生与操作相关的 8 种并发症,包括支架移位(n=4)、肺栓塞(n=2)和肺水肿(n=2)。此外,在支架置入后,抗凝治疗观察到 3 例出血,6 个月内有 4 例复发,分别在第 22、36、51 和 58 天。病变处压力梯度(≥20mmHg)被用作支架治疗 SVCS 临床疗效的预测因素。

结论

血管内支架置入术是治疗恶性 SVCS 的一种安全有效的方法,尤其是对病变处压力梯度≥20mmHg 的患者。

相似文献

1
Percutaneous Endovascular Stent Placement for Treatment of Malignant Superior Vena Cava Syndrome: A Retrospective Review.经皮腔内血管支架置入术治疗恶性上腔静脉综合征:回顾性研究。
Ann Vasc Surg. 2022 Mar;80:325-332. doi: 10.1016/j.avsg.2021.10.025. Epub 2021 Nov 12.
2
Endovascular treatment of malignant superior vena cava syndrome secondary to lung cancer.肺癌继发恶性上腔静脉综合征的血管内治疗
Hosp Pract (1995). 2017 Aug;45(3):70-75. doi: 10.1080/21548331.2017.1342507. Epub 2017 Jun 26.
3
Percutaneous transluminal stenting for superior vena cava syndrome caused by malignant tumors: a single-center retrospective study.经皮腔内血管成形术支架置入治疗恶性肿瘤引起的上腔静脉综合征:单中心回顾性研究。
J Cardiothorac Surg. 2021 Mar 20;16(1):39. doi: 10.1186/s13019-021-01418-w.
4
Stent Implantation for Superior Vena Cava Syndrome of Malignant Cause.恶性病因导致的上腔静脉综合征的支架植入术
Rofo. 2017 May;189(5):423-430. doi: 10.1055/s-0042-122147. Epub 2017 Feb 2.
5
Endovascular treatment of malignant superior vena cava syndrome: results and predictive factors of clinical efficacy.血管内治疗恶性上腔静脉综合征:临床疗效的结果和预测因素。
Cardiovasc Intervent Radiol. 2013 Feb;36(1):140-9. doi: 10.1007/s00270-011-0310-z. Epub 2011 Dec 7.
6
Use of self-expanding vascular endoprostheses in superior vena cava syndrome.自膨式血管内支架在上腔静脉综合征中的应用。
Eur J Cardiothorac Surg. 2003 Aug;24(2):208-11. doi: 10.1016/s1010-7940(03)00293-8.
7
The role of self-expanding vascular stent in superior vena cava syndrome for advanced tumours.自膨式血管支架在晚期肿瘤引起的上腔静脉综合征中的作用。
Ann R Coll Surg Engl. 2021 Apr;103(4):296-301. doi: 10.1308/rcsann.2020.7127. Epub 2021 Mar 8.
8
Percutaneous stenting of superior vena cava syndrome: treatment outcome in patients with benign and malignant etiology.经皮上腔静脉综合征支架置入术:良性和恶性病因患者的治疗结果
Vascular. 2007 Sep-Oct;15(5):314-21. doi: 10.2310/6670.2007.00067.
9
Safety and efficacy of large-bore uncovered stents for treating malignant superior vena cava syndrome.大口径无覆膜支架治疗恶性上腔静脉综合征的安全性和有效性。
Eur J Radiol. 2024 Jun;175:111446. doi: 10.1016/j.ejrad.2024.111446. Epub 2024 Mar 25.
10
[Effectiveness of endovascular prostheses as initial treatment for superior vena cava syndrome of malignant cause].[血管内假体作为恶性原因导致的上腔静脉综合征初始治疗的有效性]
Med Clin (Barc). 2013 Jan 19;140(2):59-65. doi: 10.1016/j.medcli.2011.11.012. Epub 2012 Jan 10.